Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,173.91
(
0.12%
)
US TECH 100
26,612.40
(
0.22%
)
Dow Jones
49,310.32
(
0.00%
)
Brent Oil
103.62
(
1.47%
)
Bitcoin
76,699.65
(
-0.87%
)
News Focus
News Focus
Post# of 2380736
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

~ Blue ~

Send PM Follow Ignore
Followers 2545
Posts 112748
Boards Moderated 1
Alias Born 08/25/2010

~ Blue ~

Re: MOMO post# 1561300

Sunday, 09/20/2015 11:20:12 PM

Sunday, September 20, 2015 11:20:12 PM

Post# of 2380736
AEZS~ MONSTER~ University of Texas Southwestern Medical Center:


"Recently, UT Southwestern participated in a study of a drug called zoptarelin doxorubicin that is expected to be the first FDA-approved drug for endometrial cancer"


Under
Access to the latest treatment

http://www.utswmedicine.org/cancer/programs/gynecologic/

FROM AEZS WEBSITE: Zoptarelin Doxorubicin Endometrial cancer

http://www.aezsinc.com/en/page.php?p=31&prod=87

follow me on BLUE SKY BREAKOUT

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today